Akari Therapeutics (AKTX) Assets Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.50% |
| Dec 31, 2025 | -5.28% |
| Sep 30, 2025 | 1,559.69% |
| Jun 30, 2025 | 902.97% |
| Mar 31, 2025 | 1,738.35% |
| Dec 31, 2024 | 1,061.01% |
| Jun 30, 2024 | -36.65% |
| Dec 31, 2023 | -68.52% |
| Jun 30, 2023 | -29.53% |
| Dec 31, 2022 | -99.96% |
| Jun 30, 2022 | 135.45% |
| Mar 31, 2022 | 148.15% |
| Dec 31, 2021 | 92,168,315.00% |
| Sep 30, 2021 | 7.48% |
| Jun 30, 2021 | -66.58% |
| Mar 31, 2021 | -19.01% |
| Dec 31, 2020 | 22.04% |
| Sep 30, 2020 | 33.37% |
| Jun 30, 2020 | 213.34% |
| Mar 31, 2020 | 17.62% |
| Dec 31, 2019 | -100.00% |
| Sep 30, 2019 | -18.69% |
| Jun 30, 2019 | -73.06% |
| Mar 31, 2019 | -67.72% |
| Dec 31, 2018 | -34.23% |
| Sep 30, 2018 | -43.70% |
| Jun 30, 2018 | -46.59% |
| Mar 31, 2018 | -30.18% |
| Dec 31, 2017 | -11.70% |
| Sep 30, 2017 | -56.93% |
| Jun 30, 2017 | -44.38% |
| Mar 31, 2017 | -42.00% |
| Dec 31, 2016 | -24.92% |
| Sep 30, 2016 | -34.23% |
| Jun 30, 2016 | 1,847.07% |
| Mar 31, 2016 | 1,358.40% |
| Dec 31, 2015 | 2,751,334.16% |
| Dec 31, 2014 | -56.66% |
| Dec 31, 2013 | 599.29% |
| Dec 31, 2012 | 4,048.15% |